Discovery of potent α1L-adrenoceptor agonists: Design and synthesis of bicyclic derivatives

被引：0
|
作者：
Suzuki, Shinya [1 ]
机构：
[1] TORAY, Kamakura, Kanagawa, Japan
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2015年 / 249卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
153
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Discovery of oxazole and triazole derivatives as potent and selective S1P1 agonists through pharmacophore-guided design
    Tian, Yulin
    Jin, Jing
    Wang, Xiaojian
    Hu, Jinping
    Xiao, Qiong
    Zhou, Wanqi
    Chen, Xiaoguang
    Yin, Dali
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 85 : 1 - 15
  • [22] Design and synthesis of alpha(2) adrenoceptor agonists.
    Wong, WC
    Dhar, M
    Sun, WY
    Tyagarajan, S
    Forray, C
    Vaysse, PJJ
    Branchek, TA
    Gluchowski, C
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 23 - MEDI
  • [23] Design and synthesis of bicyclic heterocycles as potent γ-secretase modulators
    Oehlrich, Daniel
    Rombouts, Frederik J. R.
    Berthelot, Didier
    Bischoff, Francois P.
    De Cleyn, Michel A. J.
    Jaroskova, Libuse
    Macdonald, Gregor
    Mercken, Marc
    Surkyn, Michel
    Trabanco, Andres A.
    Tresadern, Gary
    Van Brandt, Sven
    Velter, Adriana I.
    Wu, Tongfei
    Gijsen, Harrie J. M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (17) : 4794 - 4800
  • [24] Age-related change of the role of α1L-adrenoceptor in canine urethral smooth muscle
    Suzuki, Y
    Moriyama, N
    Okaya, Y
    Nishimatsu, H
    Kawabe, K
    Aisaka, K
    GENERAL PHARMACOLOGY, 1999, 33 (04): : 347 - 354
  • [25] Identification of the α1L-adrenoceptor in rat cerebral cortex and possible relationship between α1L- and α1A-adrenoceptors
    Morishima, S.
    Suzuki, F.
    Yoshiki, H.
    Anisuzzaman, A. S. Md
    Sathi, Z. S.
    Tanaka, T.
    Muramatsu, I.
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 153 (07) : 1485 - 1494
  • [26] Discovery of novel N-phenylglycine derivatives as potent and selective β3-adrenoceptor agonists for the treatment of frequent urination and urinary incontinence
    Tanaka, N
    Tamai, T
    Mukaiyama, H
    Hirabayashi, A
    Muranaka, H
    Akahane, S
    Miyata, H
    Akahane, M
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (09) : 1436 - 1445
  • [27] The discovery and synthesis of highly potent, A2a receptor agonists
    Keeling, SE
    Albinson, FD
    Ayres, BE
    Butchers, PR
    Chambers, CL
    Cherry, PC
    Ellis, F
    Ewan, GB
    Gregson, M
    Knight, J
    Mills, K
    Ravenscroft, P
    Reynolds, LH
    Sanjar, S
    Sheehan, MJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (04) : 403 - 406
  • [28] The α1L-adrenoceptor subtype in the lower urinary tract:: a comparison of human urethra and prostate
    Fukasawa, R
    Taniguchi, N
    Moriyama, N
    Ukai, Y
    Yamazaki, S
    Ueki, T
    Kameyama, S
    Kimura, K
    Kawabe, K
    BRITISH JOURNAL OF UROLOGY, 1998, 82 (05): : 733 - 737
  • [29] Comparison of toxicity and toxicokinetics/pharmacokinetics of an α1L-adrenoceptor agonist in rats and rhesus monkeys
    Matsumaru, T
    Sugiura, R
    Sakai, K
    Igarashi, T
    Kuno, T
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 (02) : 273 - 283
  • [30] Ligand design and synthesis of new imidazo[5,1-b]quinazoline derivatives as α1-adrenoceptor agonists and antagonists
    Ismail, MAH
    Aboul-Enein, MNY
    Abouzid, KAM
    Serya, RAT
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (04) : 898 - 910
12345